Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewsWire • 10/27/26
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFSBusiness Wire • 09/10/26
Repligen Corporation (RGEN) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and PrecigenZacks Investment Research • 08/27/26
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare ConferenceGlobeNewsWire • 08/26/26
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.24/7 Wall Street • 08/25/26
Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to TradeZacks Investment Research • 07/30/26